Jakob Frimodt-Møller

Author

Also Known As

J FRIMODT-MOLLER, J Frimodt-Moller, J Frimodt-Möller, J Frimodt-Møller, J. Frimodt-Möller, J. Frimodt-Møller, Jakob Frimodt-Møller, Nancy E. Freitag

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Statens Serum Institut University of Copenhagen University of Rhode Island Rigshospitalet Regionshospital Nordjylland

About

Jakob Frimodt-Møller is an author at Statens Serum Institut specializing in medicine, microbiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	826
2	Health Sciences	7	7	738
3	Epidemiology	3	3	577
4	Natural Sciences	2	2	88
5	Biology	1	1	55

Jakob Frimodt-Møller

Publications

Citations

H-Index

Page 1

	Year	Citations
Origins of the <i>E. coli</i> Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany David A. Rasko, Dale R. Webster, Jason W. Sahl, New England Journal of Medicine	2011	820
Genomic epidemiology of the <i>Escherichia coli</i> O104:H4 outbreaks in Europe, 2011 Yonatan H. Grad, Marc Lipsitch, Michael Feldgarden, Proceedings of the National Academy of Sciences Molecular EpidemiologyPathogen DetectionGenomic EpidemiologyGenetic EpidemiologyDisease Outbreak	2012	276
Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011 Flemming Scheutz, Eva Møller Nielsen, Jakob Frimodt-Møller, Eurosurveillance Pathogen DetectionDiagnosisDisease DetectionJune 2011Infection Control	2011	256
Prevalence and Characteristics of the Epidemic Multiresistant Escherichia coli ST131 Clonal Group among Extended-Spectrum Beta-Lactamase-Producing E. coli Isolates in Copenhagen, Denmark Bente Olesen, Dennis Schrøder Hansen, Frida Nilsson, Journal of Clinical Microbiology	2013	93
Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts Jakob Frimodt-Møller, Elio Rossi, Janus A. J. Haagensen, Scientific Reports	2018	73
The Role of Efflux Pumps in the Transition from Low-Level to Clinical Antibiotic Resistance Anna Ebbensgaard, Anders Løbner‐Olesen, Jakob Frimodt-Møller Antibiotics Clinical Antibiotic ResistanceSelective PressureAntibiotic ResistanceDrug ResistanceClinical Resistance	2020	60
The Streptomycin-Treated Mouse Intestine Selects <i>Escherichia coli envZ</i> Missense Mutants That Interact with Dense and Diverse Intestinal Microbiota Mary Leatham‐Jensen, Jakob Frimodt-Møller, Jimmy Adediran, Infection and Immunity DysbiosisMicrobial PathogensEscherichia ColiDigestive TractBacterial Pathogens	2012	57
Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract Infection Mary Leatham‐Jensen, Matthew E. Mokszycki, David Rowley, mSphere	2016	56
Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. Leif Breum, K. Stengaard‐Pedersen, Jakob Frimodt-Møller PubMed	1994	55
Oxidative DNA damage is instrumental in hyperreplication stress-induced inviability of Escherichia coli Godefroid Charbon, Louise Bjørn, Belén Mendoza-Chamizo, Nucleic Acids Research Dna DamageGeneticsMolecular BiologyEscherichia ColiCell Cycle	2014	55

Page 1